Abstract
Comparing Pazopanib, Sunitinib, Cabozantinib, Axitinib-Pembrolizumab, and Ipilimumab-Nivolumab Therapy For Metastatic Renal Cancer Metastatic renal cell carcinoma (mRCC) poses significant challenges in treatment. Here, we evaluate the outcomes of patients with…




















